Qube Research & Technologies (QRT)
LAB icon

Qube Research & Technologies (QRT)’s Standard BioTools LAB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648K Buy
704,407
+487,258
+224% +$590K ﹤0.01% 2654
2025
Q4 		$278K Sell
217,149
-65,694
-23% -$88.3K ﹤0.01% 2971
2025
Q3 		$368K Sell
282,843
-158,258
-36% -$207K ﹤0.01% 2795
2025
Q2 		$529K Buy
441,101
+20,979
+5% +$23.3K ﹤0.01% 2672
2025
Q1 		$454K Sell
420,122
-71,063
-14% -$99.8K ﹤0.01% 2577
2024
Q4 		$860K Buy
491,185
+353,045
+256% +$658K ﹤0.01% 2243
2024
Q3 		$267K Sell
138,140
-1,090,992
-89% -$2.14M ﹤0.01% 2471
2024
Q2 		$2.18M Sell
1,229,132
-487,835
-28% -$1.19M ﹤0.01% 1579
2024
Q1 		$4.65M Buy
+1,716,967
New +$4.14M 0.01% 1276
2023
Q4 		– Sell
-19,085
Closed -$55.3K – 4559
2023
Q3 		$55.3K Buy
+19,085
New +$49.9K ﹤0.01% 2841
2023
Q2 		– Sell
-10,968
Closed -$21.4K – 2722
2023
Q1 		$21.4K Buy
+10,968
New +$21.7K ﹤0.01% 2303
2022
Q4 		– Sell
-61,366
Closed -$68K – 2765
2022
Q3 		$68K Sell
61,366
-6,192
-9% -$9.36K ﹤0.01% 2071
2022
Q2 		$108K Buy
+67,558
New +$167K ﹤0.01% 1920

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LAB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Standard BioTools (LAB) stake by 224% in Q1 2026, buying an estimated $590K and bringing the position to 704,407 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #2654.

Qube Research & Technologies (QRT) first reported a position in LAB in Q2 2022 and has held it in 13 quarters since. The position peaked at $4.65M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Qube Research & Technologies (QRT) held 704,407 shares of Standard BioTools worth $648K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 487,258 Standard BioTools shares in Q1 2026, an estimated $590K.
  • Standard BioTools made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2654 holding.
  • Qube Research & Technologies (QRT) first reported a position in Standard BioTools in Q2 2022 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s Standard BioTools position peaked at $4.65M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.